Skip to main content

Grundlagen der Theophyllintherapie: Durchführung und Bewertung von Konzentrationsbestimmungen im Serum

  • Chapter
Konzentrationsmessungen von Pharmaka, Bedeutung für Klinik und Praxis
  • 21 Accesses

Zusammenfassung

Theophyllin (1,3-Dimethylxanthin) wurde als ein wirkungsbestimmender Inhaltsstoff der Blätter des Teestrauchs Ende des 19. Jahrhunderts isoliert und seine Struktur in der ersten Dekade des 20. Jahrhunderts aufgeklärt. Mit der Herstellung des Theophyllin-Aethylendiamin-Komplexes (Aminophyllin) wurde die Substanz infolge dessen besserer Löslichkeit intravenös einsetzbar. Die Indikationen ergeben sich aus dem Wirkungsprofil, das dem anderer in der Natur vorkommender Methylxanthine (Koffein, Theobromin) qualitativ entspricht:

  • Stimulation von Zns-Funktionen (vegetativ, motorisch, sensorisch und psychisch)

  • positiv inotrope und chronotrope Wirkung am Herzen

  • Relaxation der glatten Muskulatur (Atemwege, Gefäße, Intestinaltrakt und Urogenitalsystem)

  • diuretischer Effekt

  • Wechselwirkung mit anderen Pharmaka (so additive oder potenzierende Effekte zu Analgetika und Spasmolytika).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 44.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 59.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literaturverzeichnis

  • Aranda, J. V., Sitar, D. S., Parsons, W. D., Loughnan, P. M, Neims, A. H.: Pharmacokinetic Aspects of Theophylline in Premature Newborns. N. Engl. J. Med. 295, 413 (1976).

    Article  PubMed  CAS  Google Scholar 

  • Beavo, J. A., Rogers, N. L, Crofford, O. B., Baird, C. E., Hardman, J. G., Sutherland, E. W., Newman, E. V.: Effects of Phosphodiesterase Inhibitors on Cyclic Amp Levels and on Lipolysis. Ann. N. Y. Acad. Sci. 185, 129 (1971).

    Article  PubMed  CAS  Google Scholar 

  • Borner, K., Staib, A. H, Schuppan, D, Molz, K. H., Lissner, R, Lichey, J.: Analytical Reliability of Methods to Determine Theophylline in Serum or Plasma. In: Methods in Clinical Pharmacology (eds., Rietbrock, N., Neuhaus, G., Woodcock, B. G.). Vieweg-Verlag, Braunschweig (im Druck).

    Google Scholar 

  • Bory, C., Baltassat, P., Porthault, M., Bethenod, M., Frederich, A., Aranda, J. V.: Metabolism of theophylline to caffeine in premature newborn infants. J. Pediatr. 94, 988 (1979).

    Article  PubMed  CAS  Google Scholar 

  • Eichler, O.: Kaffee und Coffein. 2. Aufl. Springer-Verlag, Berlin, Heidelberg, New York, 1976.

    Book  Google Scholar 

  • Ellis, E. F., Koysooko, R., Levy, G.: Pharmacokinetics of Theophylline in Children with Asthma. Pediatrics 58, 542 (1976).

    PubMed  CAS  Google Scholar 

  • Ellis, E. F.: Asthma in Childhood: Clinical Pharmacology of Theophylline in Asthmatic Children. New Directions in Asthma (ed. M. Stein) Americ. Coll. Chest Physic. Park Ridge, Ill., 1975, 317–323.

    Google Scholar 

  • Eppel, M. L., Mackay, A., Oliver, J. S., Ramsay, L. E.: Factors Influencing the Dose of Oral Aminophylline. Brit. J. Clin. Pharmacol. 8, 834p (1979).

    Google Scholar 

  • Forth, W., Henschler, D., Rummel, W.: Allgemeine und spezielle Pharmakologie und Toxikologie. Bibl. Inst. Mannheim — Wien — Zürich 1975.

    Google Scholar 

  • Gal, P., Jusko, W. J., Yurchak, A. M., Franklin, B. A.: Theophylline Dispositon in Obesity. Clin. Pharmacol. Ther. 23, 438 (1978).

    PubMed  CAS  Google Scholar 

  • Giacoia, G., Jusko, W. J., Menke, J., Koup, J. R.: Theophylline Pharmacokinetics in Premature Infants with Apnea. J. Pediatr. 89, 829 (1976).

    Article  PubMed  CAS  Google Scholar 

  • Heinz, N., Rietbrock, N.: Relationship between dose and Plasma Level of Digoxin and Patient Characteristics. Europ. J. Clin. Pharmacol. 15, 109 (1979).

    Article  CAS  Google Scholar 

  • Hendeles, L, Weinberger, M., Johnson, G.: Monitoring Serum Theophylline Levels. Clin. Pharmacokin. 3, 294 (1978).

    Article  CAS  Google Scholar 

  • Hendeles, L, Weinberger, M., Wyatt, R.: Guide to Oral Theophylline Therapy for the Treatment of Chronic Asthma. Am. J. Dis. Child 132, 876 (1978).

    PubMed  CAS  Google Scholar 

  • Hunts, S. N., Jusko, W. J., Yurchak, A. M.: Effect of Smoking on Theophylline Disposition. Clin. Pharmacol. Ther. 19, 546 (1976).

    Google Scholar 

  • Jenne, J. W., Nagasawa, H., McHUGH, R., Mac Donald, F., Wyse, E.: Decreased theophylline half-life in cigarette smokers. Life Sciences 17, 195, 1975.

    Article  PubMed  CAS  Google Scholar 

  • Jenne, J. W., Nagasawa, H. T., Thompson, R. D.: Relationship of Urinary Metabolites of Theophylline to Serum Theophylline Levels. Clin. Pharmacol. Ther. 19, 375 (1976).

    PubMed  CAS  Google Scholar 

  • Jusko, W. J, Koup, J. R., Vance, J. W., Schentag, J.J., Kuritzky, P.: Intravenous Theophylline Therapy: Nomogram Guidelines. Ann. Intern. Med. 86, 400 (1977).

    Article  PubMed  CAS  Google Scholar 

  • Jusko, W. J., Schentag, J. J., Clark, J. H., Gardner, M., Yurchak, A. M.: Enhanced Biotransformation of Theophylline in Marihuana and Tobacco Smokers. Clin. Pharmacol. Ther. 24, 406 (1978).

    CAS  Google Scholar 

  • Kadlec, G. J., Le Thanh HA, Jarboe, C. H., Richards, D., Karibo, J. M.: Theophylline Half-Live in Infants and Young Children. Ann. Allergy 40, 303 (1978).

    PubMed  CAS  Google Scholar 

  • Kappas, A., Alvares, A. P., Anderson, K. E., Pantuck, E. J., Pantuck, C. B., Chang, R., Conney, A. H.: Effect of Charcoal-Broiled Beef on Antipyrine and Theophylline Metabolism. Clin. Pharmacol. Ther. 23, 445 (1978).

    PubMed  CAS  Google Scholar 

  • Kellermann, G., Luythen-Kellermann, M.: Benzo (a) pyrene Metabolism and Plasma Elimination Rates of Phenacetin, Acetanilide and Theophylline in Man. Pharmacology 17, 191 (1978).

    Article  PubMed  CAS  Google Scholar 

  • Klotz, U.: Klinische Pharmakokinetik. G. Fischer Verlag, Stuttgart — New York 1979.

    Google Scholar 

  • Koysooko, R., Ellis, E. F., Levy, G.: Relationship between theophylline Concentration in Plasma and Saliva of Man. Clin. Pharmacol. Ther. 15, 454 (1974).

    PubMed  CAS  Google Scholar 

  • Lawyer, C. H., Keppel, J., Bardana, E. J.: Theophylline in Liver Disease. N. Engl. J. Med. 297, 112 (1977).

    Article  Google Scholar 

  • Levy, G., Ellis, E. F., Koysooko, R.: Indirect Plasma-Theophylline Monitoring in Asthmatic Children by Determination of Theophylline Concentration in Saliva. Pediatrics 53, 873 (1974).

    PubMed  CAS  Google Scholar 

  • Lohmann, S., Miech, R. P.: Theophylline Metabolism by the Rat Liver Microsomal System. J. Pharmacol. exp. ther. 196, 213 (1976).

    PubMed  CAS  Google Scholar 

  • Loughnan, P. M, Sitar, D. S., Ogilvie, R. I., Eisen, A., Fox, Z., Neims, A. H.: Pharmacokinetic Analysis of the Disposition of Intravenous Theophylline in Young Children. Pediatrics 88, 874 (1976).

    Article  CAS  Google Scholar 

  • Mangione, A., Imhoff, T. E., Lee, R. V., Shum, L. Y., Jusko, W. J.: Pharmacokinetics of Theophylline in Hepatic Disease. Chest 73, 616 (1978).

    Article  PubMed  CAS  Google Scholar 

  • Miech, R. P., Lohman, S. M.: Metabolism and Pharmacodynamics of Theophylline. New Directions in Asthma (ed. M. Stein) Americ. Coll. Chest Physic. Park Ridge, Ill. 1975, 377–390.

    Google Scholar 

  • Mitenko, P. A., Ogilvie, R. I.: Rapidly Achieved Plasma Concentration Plateaus, with Observations on Theophylline Kinetics. Clin. Pharmacol. Ther. 13, 329 (1972).

    PubMed  CAS  Google Scholar 

  • Mitenko, P. A., Ogilvie, R. I.: Pharmacokinetics of Intravenous Theophylline. Clin. Pharmacol. Ther. 14, 509 (1973).

    PubMed  CAS  Google Scholar 

  • Nielsen-Kudsk, F., Magnussen, I., Jakobsen, P.: Pharmacokinetics of Theophylline in Ten Elderly Patients. Acta pharmacol. et toxicol 42, 226 (1978).

    Article  CAS  Google Scholar 

  • Ogilvie, R. I.: Clinical Pharmacokinetics of Theophylline. Clin. Pharmacokin. 3, 267 (1978).

    Article  CAS  Google Scholar 

  • Pfeifer, H.J., Greenblatt, D.J., Friedman, P.: Effects of three Antibiotics on Theophylline Kinetics. Clin. Pharmacol. Ther. 26, 36 (1979).

    PubMed  CAS  Google Scholar 

  • Piafsky, K. M., Ogilvie, R. I.: Drug Therapy. Dosage of Theophylline in Bronchial Asthma. N. Engl. J. Med. 292, 1218 (1975).

    Article  PubMed  CAS  Google Scholar 

  • Piafsky, K. M., Sitar, D. S., Rangno, R. E., Ogilvie, R. I.: Theophylline Kinetics in Acute Pulmonary Edema. Clin. Pharmacol. Ther. 21, 310 (1977).

    PubMed  CAS  Google Scholar 

  • Piafsky, K. M., Sitar, D. S., Rangno, R. E., Ogilvie, R. I.: Theophylline Disposition in Patients with Hepatic Cirrhosis. N. Engl. J. Med. 296, 1495 (1977).

    Article  PubMed  CAS  Google Scholar 

  • Powell, J. R., Thiercelin, J. F., Vozeh, S., Sansom, L., Riegelman, S.: The Influence of Cigarette Smoking and Sex on Theophylline Disposition. Am. Rev. Resp. Dis. 116, 17 (1977).

    PubMed  CAS  Google Scholar 

  • Rietbrock, N.: Wissenswertes über Pharmakokinetik. Kurse ärztl. Fortbil. 29, 483 (1979).

    Google Scholar 

  • Schack, J. A., Waxler, S. H.: An Ultraviolet Spectrophotometric Method for the Determination of Theophylline and Theobromine in Blood and Tissues. J. Pharmacol, exp. ther. 97, 283 (1949).

    CAS  Google Scholar 

  • Simons, K.J., Simons, F. E., Briggs, C. J., LO, L.: Theophylline Protein Binding in Humans. J. Pharmac. Sci. 68, 252 (1979).

    Article  CAS  Google Scholar 

  • Slotfeld, M. L., Johnson, C. E., Grambau, G., Weg, J. G.: Reliability of Theophylline Clearance in Determining Chronic Oral Dosage Regimens. Am. J. Hosp. Pharm. 37, 66 (1977).

    Google Scholar 

  • Spangler, D. L., Kalof, D. D., Bloom, F. L., Wittig, H. J.: Theophylline Bioavailability Following Oral Administration of Six Sustained-Release preparations. Ann. Allergy 40, 6 (1978).

    PubMed  CAS  Google Scholar 

  • Staib, A., H., Schuppan, D., Lissner, R., Zilly, W., v. Bomhard, G., Richter, E.: Theophylline plasma Pharmacokinetics and Urinary Metabolite Pattern in Patients with Liver Diseases. Internat. Sympos. Methods in Clinical Pharmacology, Frankfurt/M., 1979. In: Methods in Clinical Pharmacology, (eds Rietbrock, N., Neuhaus, G., Woodcock, B. G.) Vieweg-Verlag, Braunschweig (im Druck).

    Google Scholar 

  • Waxler, S. H., Schack, J. A.: Administration of Aminophylline (Theophylline Ethylenediamine). J. Amer. Med. Ass. 143, 736 (1950).

    Article  CAS  Google Scholar 

  • Weinberger, M., Hendeles, L., Bighley, L.: The Relation of Product Formulation to Absorption of Oral Theophylline. N. Engl. J. Med. 299, 852 (1978).

    Article  PubMed  CAS  Google Scholar 

  • Zilly, W., Staib, A. H., Epping, J., Schuppan, D.: Der Einfluß von Rifampicin auf die Pharmakokinetik von Theophyllin. — 86. Tagung der Deutschen Gesellschaft für innere Medizin, Wiesbaden 13.–15. April 1980, Vortrag 180.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

K. Hierholzer N. Rietbrock

Rights and permissions

Reprints and permissions

Copyright information

© 1980 Springer Fachmedien Wiesbaden

About this chapter

Cite this chapter

Staib, A.H. (1980). Grundlagen der Theophyllintherapie: Durchführung und Bewertung von Konzentrationsbestimmungen im Serum. In: Hierholzer, K., Rietbrock, N. (eds) Konzentrationsmessungen von Pharmaka, Bedeutung für Klinik und Praxis. Vieweg+Teubner Verlag, Wiesbaden. https://doi.org/10.1007/978-3-663-14065-8_6

Download citation

  • DOI: https://doi.org/10.1007/978-3-663-14065-8_6

  • Publisher Name: Vieweg+Teubner Verlag, Wiesbaden

  • Print ISBN: 978-3-528-07904-8

  • Online ISBN: 978-3-663-14065-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics